XML 14 R2.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Jun. 30, 2022
Dec. 31, 2021
Assets    
Cash and cash equivalents $ 2,567 $ 4,544
Receivables 43 47
Inventories:    
Leaf tobacco 605 744
Other raw materials 183 166
Work in process 29 23
Finished product 327 261
Inventory, net 1,144 1,194
Other current assets 332 298
Total current assets 4,086 6,083
Property, plant and equipment, at cost 4,345 4,432
Less accumulated depreciation 2,788 2,879
Property, plant and equipment, net 1,557 1,553
Goodwill 5,177 5,177
Other intangible assets, net 12,372 12,306
Investments in equity securities ($451 million and $1,720 million at June 30, 2022 and December 31, 2021, respectively, measured at fair value) 12,590 13,481
Other assets 964 923
Total Assets 36,746 39,523
Liabilities    
Current portion of long-term debt 2,634 1,105
Accounts payable 396 449
Accrued liabilities:    
Marketing 708 664
Settlement charges 1,749 3,349
Other 1,194 1,365
Dividends payable 1,630 1,647
Total current liabilities 8,311 8,579
Long-term debt 25,046 26,939
Deferred income taxes 3,898 3,692
Accrued pension costs 197 200
Accrued postretirement health care costs 1,437 1,436
Other liabilities 260 283
Total liabilities 39,149 41,129
Contingencies (Note 11)
Stockholders’ Equity (Deficit)    
Common stock, par value $0.33 1/3 per share (2,805,961,317 shares issued) 935 935
Additional paid-in capital 5,861 5,857
Earnings reinvested in the business 30,252 30,664
Accumulated other comprehensive losses (2,377) (3,056)
Cost of repurchased stock (1,003,717,832 shares at June 30, 2022 and 982,785,699 shares at December 31, 2021) (37,074) (36,006)
Total stockholders’ equity (deficit) (2,403) (1,606)
Total Liabilities and Stockholders’ Equity (Deficit) $ 36,746 $ 39,523